Our unique, integrated approach offers both clinical and research services positioning us as partner with patients, providers, and pharma to drive precision medicine in cancer and other diseases.
We are led by a team of industry professionals, MDs, and PhDs, with extensive experience in molecular diagnostics.
Genetics Institute of America (GIA) is a leading cancer diagnostics and pharma-services laboratory serving physicians and their clients with advanced, prognostic, and predictive testing.
Genetics Institute of America was founded to provide high quality, physician and patient focused, molecular diagnostics that can truly impact patient care.
Our unique, integrated approach offers both clinical and research services positioning us as partners with patients, providers, and pharma to drive precision medicine in cancer and other diseases.
Genetics Institute of America is a CAP Accredited and CLIA Certified clinical and research laboratory performing advanced molecular diagnostics testing to provide clinical decision support while driving patient care and safety.
Genetic testing involves examining your DNA, the chemical database that carries instructions for your body’s functions. Certain differences in your genes (called “pathogenic variants”) could put you at risk for disease, such as cancer, or affect the types of medications you would be able to take. Genetic testing is useful in many areas of medicine and may change the medical care you receive.
Genetics Institute of America takes pride in the community we are a part of and has created a corporate culture that aims to play a greater role in community solutions. We are convinced that by putting in the work, we help contribute to the revitalization of our local community, specifically within initiatives that focus on the individuals and families we serve.